Importance of blood pressure variability in the assessment of cardiovascular risk and benefits of antihypertensive therapy

Expert Review of Clinical Pharmacology

Volumn 3, Issue 5, 2010, Pages 617-621

  Höcht, Christian ^a   Bertera, Facundo Martín ^a   Taira, Carlos Alberto ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

amlodipine; atenolol; blood pressure variability; hypertension; stroke; target organ damage

Indexed keywords

AMILORIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG EFFECT; HUMAN; HYPERTENSION; REVIEW; STROKE;

EID: 77956816389     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/ecp.10.44     Document Type: Review

References (20)

1. Mancia G, De Backer G, Dominiczak A et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J. Hypertens. 25(9), 1751-1762 (2007).
2. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6), 1206-1252 (2003).
3. Parati G. Blood pressure variability: its measurement and significance in hypertension. J. Hypertens. 23(Suppl. 1), S19-S25 (2005).
4. Parati G, Bilo G, Valentini M. Blood pressure variability: methodological aspects, pathophysiological and clinical implications. In: Manual of Hypertension of the European Society of Hypertension. Part 2. Mancia G, Grassi G, Kjeldsen SE (Eds). Informa Healthcare, London, UK 61-71 (2008).
5. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol. Sci. 26(8), 388-390 (2005).
6. Stauss HM. Identification of blood pressure control mechanisms by power spectral analysis. Clin. Exp. Pharmacol. Physiol. 34(4), 362-388 (2007).
7. Rothwell PM, Howard SC, Dolan E et al. Effects of b blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 9(5), 469-480 (2010).
8. Rothwell PM, Howard SC, Dolan E et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375(9718), 895-905 (2010).
9. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J. Hypertens. 5(1), 93-98 (1987).
10. Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 102(13), 1536-1541 (2000).
11. Kikuya M, Hozawa A, Ohokubo T et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36(5), 901-906 (2000).
12. Imholz BP, Langewouters GJ, van Montfrans GA et al. Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension 21(1), 65-73 (1993).
13. Omboni S, Parati G, Frattola A et al. Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension 22(1), 26-33 (1993).
14. Pierdomenico SD, Di Nicola M, Esposito AL et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 22(8), 842-847 (2009).
15. Taira CA, Carranza A, Mayer M, Di Verniero C, Opezzo JA, Höcht C. Therapeutic implications of b-adrenergic receptor pharmacodynamic properties. Curr. Clin. Pharmacol. 3(3), 174-184 (2008).
16. Di Verniero CA, Bertera F, Buontempo F et al. Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension. J. Pharm. Pharmacol. 62(7), 890-900 (2010).
17. Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am. J. Hypertens. 11(3 Pt 1), 272-279 (1998).
18. Soucek M, Rihacek I, Frana P. A comparison of the trough-to-peak ratio of cardio-selective b-blockers in patients with newly diagnosed hypertension. Blood Press. Monit. 11(6), 337-342 (2006).
19. Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H. Comparing b-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 106(4), 199-206 (2006).
20. Palatini P, Mugellini A, Spagnuolo V et al. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study). Blood Press. Monit. 9(2), 91-97 (2004).